AI-generated summary
The authors studied refined photobiomodulation therapy using an 830 nm infrared LED in a mouse model of dextran sodium sulfate-induced colitis. They report that treatment reduced colon inflammation and tissue damage, restored colon length, and was associated with changes in immune pathways and gut microbiota. The study was conducted in mice, so results may not apply to people.
- Who or what was studied
- Mice with dextran sodium sulfate-induced colitis
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The study was conducted in a mouse model, so findings may not translate to human inflammatory bowel disease.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.